Clinical significance of combined detection of CEA,CA19-9 and CA72-4 in patients with gastric cancer
Hui Qian
Abstract
Hui Qian
Abstract
Objective: To investigate the clinical value of serum CEA、CA19-9、CA72-4 in patients with gastric cancer.Methods: The levels of serum CEA,CA19-9 and CA72-4 were measured in patients with gastric cancer,benign gastric diseases and normal control by an electrochemiluminescence method,the data were carried on statistics analysis.Results: The levels of serum CEA,CA19-9 and CA72-4 in patients with gastric cancer were significantly higher than in benign gastric disease patients and normal control,the difference was statistically significant(P0.01).The levels of serum CEA,CA19-9 and CA72-4 showed no significant difference among different differentiation groups of gastric cancer(P0.05),and between lymph node metastasis group and non-metastasis group(P0.05).ROC curve were applied in analysis of CEA,CA19-9 and CA72-4 in gastric cancer,the area under the curve were 0.694±0.051,0.651±0.053,0.703±0.049,respectively.Compared with benign gastric diseases and normal control,the difference was statistically significant(P0.01).Conclusion: Combined detection of the levels of serum CEA,CA19-9 and CA72-4 in patients with gastric cancer can improve the diagnostic sensitivity,and provide useful clinical information on the severity and prognosis in gastric cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the clinical value of serum CEA、CA19-9、CA72-4 in patients with gastric cancer.Methods: The levels of serum CEA,CA19-9 and CA72-4 were measured in patients with gastric cancer,benign gastric diseases and normal control by an electrochemiluminescence method,the data were carried on statistics analysis.Results: The levels of serum CEA,CA19-9 and CA72-4 in patients with gastric cancer were significantly higher than in benign gastric disease patients and normal control,the difference was statistically significant(P0.01).The levels of serum CEA,CA19-9 and CA72-4 showed no significant difference among different differentiation groups of gastric cancer(P0.05),and between lymph node metastasis group and non-metastasis group(P0.05).ROC curve were applied in analysis of CEA,CA19-9 and CA72-4 in gastric cancer,the area under the curve were 0.694±0.051,0.651±0.053,0.703±0.049,respectively.Compared with benign gastric diseases and normal control,the difference was statistically significant(P0.01).Conclusion: Combined detection of the levels of serum CEA,CA19-9 and CA72-4 in patients with gastric cancer can improve the diagnostic sensitivity,and provide useful clinical information on the severity and prognosis in gastric cancer.
Key concepts: Medicine, Internal medicine, CA19-9, Cancer, Gastroenterology, Lymph node metastasis, Clinical significance, Significant difference